The observation of differential coating of bacteria with IgA in IBD and malnourishment, the differences in mutational patterns in TG2-reactive B cells, heightened susceptibility to gastrointestinal infection and a variety of outcomes for patients with sIgAD showcase the nuanced B cell response in the GALT and its clinical implications. Here, CD79A is linked to inflammatory bowel disease.